Goldline Pharmaceutical IPO Allotment Date and Status Check Guide
Goldline Pharmaceutical IPO allotment date in focus today; latest GMP, step-by-step guide to check status
Mint
Image: Mint
Goldline Pharmaceutical's IPO share allotment is set for today, May 15. The IPO was oversubscribed by 840.74 times, with shares expected to be credited to successful applicants' demat accounts on May 18. The estimated listing price is ₹58, reflecting a 34.88% discount from the IPO price of ₹43.
- 01The Goldline Pharmaceutical IPO subscription period ran from May 12 to May 14.
- 02The IPO's grey market premium (GMP) is currently +15, indicating strong investor demand.
- 03Shares will be credited to demat accounts on May 18, with refunds for unsuccessful applicants starting the same day.
- 04Investors can check their allotment status on the Bigshare Services website or the BSE site.
- 05The listing date for Goldline Pharmaceutical on the BSE SME is scheduled for May 19.
Advertisement
In-Article Ad
The allotment of shares for Goldline Pharmaceutical's initial public offering (IPO) will be finalized today, May 15. The IPO, which opened for subscription from May 12 to May 14, saw an impressive oversubscription rate of 840.74 times. Investors who successfully receive shares will see them credited to their demat accounts on May 18, while refunds for unsuccessful applicants will also begin on that date. The grey market premium (GMP) for the IPO stands at +15, suggesting a positive outlook for the listing. Based on this GMP, the expected listing price of Goldline shares is approximately ₹58, which is 34.88% lower than the IPO price of ₹43. Investors can check their allotment status on the registrar's portal, Bigshare Services Pvt Ltd, or via the BSE website. The listing on the BSE SME is anticipated for May 19.
Advertisement
In-Article Ad
The successful allotment of shares could lead to potential gains for investors upon listing, while those who did not receive shares will initiate refunds.
Advertisement
In-Article Ad
Reader Poll
Are you planning to invest in upcoming IPOs?
Connecting to poll...
Read the original article
Visit the source for the complete story.